Handelsbanken Fonder Ab Opko Health, Inc. Transaction History

Handelsbanken Fonder Ab

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 01, 2024	SELL	$1.23 - $1.63 $11,562 - $15,321	-9,400 Reduced 10.91%	76,721 $116,000
Q2 2023 Aug 02, 2023	SELL	$1.37 - $2.17 $21,235 - $33,635	-15,500 Reduced 15.25%	86,121 $187,000
Q1 2022 May 11, 2022	SELL	$2.87 - $4.93 $63,140 - $108,460	-22,000 Reduced 17.8%	101,621 $350,000
Q4 2021 Feb 08, 2022	BUY	$3.52 - $5.15 $155,584 - $227,630	44,200 Added 55.65%	123,621 $595,000
Q2 2021 Aug 03, 2021	BUY	$3.33 - $4.55 $78,588 - $107,380	23,600 Added 42.28%	79,421 $322,000
Q2 2020 Aug 13, 2020	BUY	$1.15 - $3.41 $64,194 - $190,349	55,821 New	55,821 $190,000

255

187M

6.03M

10.1M

Ticker OPK
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 771,960,000
Market Cap $1.19B
Description
OPKO Health, Inc., a healthcare company, engages in the diagnostics and pharmaceuticals businesses in the United States, Ireland, Chile, Spain, Israel, Mexico, and internationally. The company's Diagnostics segment operates BioReference Laboratories that offers laboratory testing services for the detection, diagnosis, evaluation, monitoring, and...

Get notified when there are updates to the investment portfolio of Handelsbanken Fonder Ab, based on Form 13F filings with the SEC.

Stay updated on Handelsbanken Fonder Ab with notifications on news.